W.-B. Yi, C. Cai / Journal of Fluorine Chemistry 130 (2009) 1054–1058
1055
2
. Experimental
2,3,4-Trimethyl-2-ethyl-2,3-dihydro-1H-1,5-benzodiazepine 4:
yellow solid; m.p. 136–137 8C (Lit. [12] 137–138 8C); IR (KBr):
n
À1
1
2.1. General remarks
3340 (NH), 1643 (C 55 N), 1593 (Ar) cm ; H NMR (300 MHz, TMS,
CDCl 0.98 (t, 3H, CH , J = 7.0 Hz), 1.25 (t, 3H, CH , J = 7.1 Hz), 1.71
(q, 2H, CH , J = 7.0 Hz), 2.16 (m, 2H, –CH ), 2.35 (s, 3H, –CH ), 2.69 (q,
2H, –CH , J = 7.1 Hz), 3.29 (br, 1H, –NH), 6.80–7.31 (m, 4H, Ar);
NMR (50 MHz, TMS, CDCl 175.6, 140.6, 138.1, 127.0, 126.2, 125.3,
3
)
d
3
3
1
13
19
H NMR, C NMR and F NMR spectra were taken with a
2
2
3
13
Bruker Advance RX300 spectrometer. GC–MS analyse was
performed on a Saturn 2000GC/MS instrument. Particle size
distribution was measured on a Mastersize2000 laser granularity
testing apparatus. IR spectra were recorded on a Bomen MB154S
infrared analyzer. Perfluorooctane and potassium perfluoroocta-
nesulfonate were commercially obtained from DeiFu Chemical Co.
of Wuhan. Other fluorous solvents were commercially obtained
from ARCOS Co. Commercially available reagents were used
without further purification.
2
C
3
) d
121.6, 70.8, 42.1, 35.6, 35.6, 26.8, 10.6, 8.4; MS(EI) m/z: 216 (7), 214
(32), 207 (93), 199 (100), 133 (20), 132 (75), 96 (27), 65 (8).
2,4-Dimethyl-3-ethyl-2-(n-propyl)-2,3-dihydro-1H-1,5-benzo-
diazepine 5: yellow solid; m.p. 138–141 8C (Lit. [20] 139–140 8C); IR
À1
1
(KBr):
TMS, CDCl
J = 7.0 Hz), 3.70 (br, 1H, –NH), 6.67–7.44 (m, 4H, Ar); C NMR
50 MHz, TMS, CDCl 173.8, 142.2, 139.6, 132.7, 126.8, 118.1,
117.3, 68.2, 45.9, 30.4, 28.3, 28.0, 12.2, 11.6, 7.8, 7.3; MS(EI) m/z: 244
n
3342 (NH), 1640 (C 55 N), 1589 (Ar) cm ; H NMR (300 MHz,
3
)
d
0.76–1.48 (m, 13H), 2.39 (s, 3H, CH ), 2.89 (q, 1H, CH,
3
13
(
3
) d
2.2. Preparation of fluorous aqueous emulsion
(
11), 202 (13), 201 (100), 161 (13), 133 (16), 132 (25), 87 (3).
10-Spirocyclopentan-1,2,3,9,10,10a-hexahydrobenzo[b]-cyclo-
Potassium perfluorooctanesulfonate (2.94 g, 5 mmol) was added
to a mixture of perfluorooctane (4.38 g, 10 mmol) and deionized
water (10 ml). The mixture was stirred for 2 h and then surged with
sonication for 2 h at ambient temperature. After the completion of
the emulsion formation, the dispersion was partially applied for the
measurement of the particle size distributions at 25 8C.
penta[e][1,4]diazepine 6: yellow solid; m.p. 134–136 8C (Lit. [8]
À1
1
134 8C); IR (KBr):
NMR (300 MHz, TMS, CDCl
CH ), 3.72 (br, 1H, –NH), 6.58–7.23 (m, 4H, Ar); C NMR (50 MHz,
TMS, CDCl 178.0, 143.2, 139.6, 132.2, 126.8, 119.1, 118.6, 68.0,
4.3, 39.2, 38.4, 33.3, 28.9, 24.2, 24.0, 23.6; MS(EI) m/z: 240 (6), 236
n
3338 (NH), 1658 (C 55 N), 1610 (Ar) cm
; H
3
) d
1.01–2.24 (m, 13H), 3.26 (m, 2H,
1
3
2
3
) d
5
2
.3. Typical procedure for the synthesis of 1,5-benzodiazepine in
(16), 207 (24), 187 (98), 145 (63), 132 (100), 92 (12), 55(6).
10-Spirocyclohexan-2,3,4,10,11,11a-hexahydro-1H-dibenzo[-
b,e][1,4]diazepine 7: yellow solid; m.p. 138–139 8C (Lit. [12] 137–
fluorous aqueous emulsion
À1
1
o-Phenylenediamine (0.22 g, 2 mmol) was added to the above
emulsion in a glass flask under vigorous stirring. After ca. 5 min,
acetophenone (0.72 g, 6 mmol) was introduced into the glass flask.
After being stirred at room temperature for 72 h, the mixture was
transferred to an extraction and separation funnel. Ether/hexane
139 8C); IR (KBr):
NMR (300 MHz, TMS, CDCl
CH ), 3.70 (br, 1H, –NH), 6.57–7.18 (m, 4H, Ar); C NMR (50 MHz,
TMS, CDCl 178.4, 142.7, 138.0, 129.4, 126.5, 121.4, 121.2, 63.0,
n
3310 (NH), 1645 (C 55 N), 1600 (Ar) cm
; H
3
) d
0.96–2.35 (m, 17H), 3.25 (m, 2H,
1
3
2
3
) d
52.8, 40.6, 39.2, 34.3, 33.3, 25.4, 24.3, 23.2, 21.7, 21.7; MS(EI) m/z:
(
1:1, 10 ml  3 ml) was added to the funnel to extract organic
268 (3), 188 (24), 145 (100), 132 (43), 92 (8), 65 (8).
substrates. The recovered emulsion was ready for further runs. The
organic extraction was washed with water (10 ml), 10% NaHCO
3
3. Results and discussion
solution (10 ml) and water (10 ml  2 ml), and dried over MgSO
4
.
The solvent was removed under reduced pressure and the residue
was purified by column chromatography on silica gel (eluent:
Initially, effect of the media on the condensation of o-
phenylenediamine with acetophenone was investigated
(Table 1). Potassium perfluorooctanesulfonate was selected as
an emulsifier because it was cheap and easily obtained from
industrial production. The control experiment showed that only
trace amount of condensation product could be obtained in water,
fluorous solvent and ordinary organic solvents. Even in the
presence of aliphatic-chain surfactants such as potassium octyl
sulfate (POS) and sodium dodecyl sulfate (SDS) at higher
temperature, no remarkable acceleration was observed. The
reaction did not improve by addition of potassium perfluoroocta-
nesulfonate, indicating that potassium perfluorooctanesulfonate
itself has almost no catalytic activity for the condensation.
CH
diphenyl-2-methyl-2,3-dihydro-1H-1,5-benzodiazepine 1 (0.44 g,
1%). All the condensation products are known compounds and
2 2
Cl /MeOH = 90/10) to give the condensation product 2,4-
7
1
13
adequately characterized by IR, H NMR, C NMR and GC–MS.
Diphenyl-2-methyl-2,3-dihydro-1H-1,5-benzodiazepine
yellow solid; m.p. 150–152 8C (Lit. [12] 151–152 8C); IR (KBr):
1:
n
À1
1
3
342 (NH), 1635 (C 55 N), 1588 (Ar) cm ; H NMR (300 MHz, TMS,
CDCl 1.76 (s, 3H, CH ), 2.93 (d, 2H, –CH , J = 0.17 Hz), 3.10 (d,
, J = 0.17 Hz), 3.36 (br, 1H, –NH), 6.80–7.71 (m, 14H, Ar);
C NMR (50 MHz, TMS, CDCl 167.4, 146.6, 140.2, 139.5, 138.2,
3
)
d
3
2
2
H, –CH
2
1
3
3
) d
129.9, 128.6, 128.4, 128.1, 127.2, 127.2, 126.4, 125.7, 121.7, 121.6,
74.1, 43.0, 29.9; MS(EI) m/z: 312 (10), 310 (14), 295 (100), 132 (65),
92 (12), 65 (8).
Table 1
2
,2,4-Trimethyl-2,3-dihydro-1H-1,5-benzodiazepine 2: white
solid; m.p. 125–126 8C (Lit. [8] 126 8C); IR (KBr): 3295 (NH), 1640
C 55 N), 1592 (Ar) cm ; H NMR (300 MHz, TMS, CDCl 1.34 (s,
), 3.45 (br, 1H, –NH),
.62–7.21 (m, 4H, Ar); C NMR (50 MHz, TMS, CDCl 171.6,
40.4, 138.0, 126.9, 125.3, 121.8, 121.6, 68.1, 45.4, 30.6, 29.5, 29.5;
a
Media effect for the condensation of o-phenylenediamine with acetophenone .
n
b
b
À1
1
Condition
Yield (%)
Condition
Yield (%)
(
3
) d
c
c,d
6
6
1
H, 2-CH
3
), 2.20 (s, 2H, –CH
2
), 2.36 (s, 3H, –CH
3
H
2
O
2
<1
<1
<1
<1
6
SDS/H
2
O
11–17
37
e
f
13
C H OH
C F /H O/KFOS
2
5
8
8
6
7
7
18
2
2
2
2
3
) d
c
C
8
F
18
C
C
C
C
C
F
F
F
F
18/H
O/KFOS
O/KFOS
71, 68, 69
c
f
n-Octane
14/H
14/H
75
54
49
58
MS(EI) m/z: 188 (40), 173 (100), 132 (64), 131 (22), 92 (10).
,2,4-Triethyl-3-methyl-2,3-dihydro-1H-1,5-benzodiazepine
: yellow solid; m.p. 143 8C (Lit. [12] 144–145 8C); IR (KBr): 3328
NH), 1645 (C 55 N), 1588 (Ar) cm ; H NMR (300 MHz, TMS, CDCl
c
f
Toluene
O/KFOS
c
f
2
C
8
F
18/H
2
O (1:1)
c,d
8
/H
2
O/KFOS
f
POS/H
2
O
8–15
10
F18/H
2
O/KFOS
3
(
n
À1
1
a
3
)
The reaction condition: phenylenediamine, 2 mmol; acetophenone, 6 mmol;
reaction over 72 h at RT.
d
3
CDCl
0.80–1.52 (m, 14H), 2.32 (m, 2H, CH
.69 (br, 1H, –NH), 6.66–7.38 (m, 4H, Ar); C NMR (50 MHz, TMS,
173.8, 142.0, 139.6, 132.7, 126.8, 118.0, 117.4, 68.3, 46.2,
2
), 2.91 (q, 1H, CH, J = 7.0 Hz),
b
13
Isolated yields based on the phenylenediamine.
c
1
0 ml of each reaction medium.
Surfactants, 10 mmol, 25–60 8C.
PFC (10 mmol), H O (10 ml) and KFOS (2 mmol).
PFC (10 mmol), H O (10 ml) and KFOS (5 mmol).
3
)
d
d
e
f
3
5.4, 28.3, 28.0, 12.2, 11.6, 7.8, 7.3; MS(EI) m/z: 244 (12), 201 (100),
2
1
61 (13), 132 (25), 131 (6), 87 (3).
2